Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen
Publikationen
Ergebnisse pro Seite:  10

Briegert, M; Enk, AH; Kaina, B

Change in expression of MGMt during maturation of human monocytes into dendritic cells

DNA Repair. Bd. 6. 2007 S. 1255-1263


Gruner, BM; Han, SR; Meyer, HG et al.

Characterization of a Catalase-Negative Methicillin-Resistant Staphylococcus aureus Strain.

J Clin Microbiol. Bd. 45. H. 8. 2007 S. 2684-5


Efferth, T; Kaina, B

Chemical Carcinogenesis: Genotoxic and Non-genotoxic Mechanisms

H. Greim and R. Snyder (Hrsg). Toxicology and Risk Assessment: A Comprehensive Introduction. John Wiley & Sons Ltd. 2007


Paulides, M; Wojnowski, L

Chemotherapeutikainduzierte Herzinsuffizienz.

Med Klin (Munich). Bd. 102. H. 7. 2007 S. 574-8



Rebillard, A; Tekpli, X; Meurette, O et al.

Cisplatin-induced apoptosis involves membrane fluidification via inhibition of NHE1 in human colon cancer cells

Cancer Res. Bd. 67. 2007 S. 7865-7874


Nagel, G; Wiewrodt, D; Perneczky, A et al.

Comparing MGMT activity and promoter methylation in glioblastomas as predictive tools

Naunyn Schmiedebergs Arch Pharmacol. Bd. 375. 2007 S. 85


Loos, M; Petry, F; Colomb, M et al.

Complement activation and innate immunity.

Immunobiology. Bd. 212. H. 4-5. 2007 S. 229-32


Bopp, T; Becker, C; Klein, M et al.

Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression.

J Exp Med. Bd. 204. H. 6. 2007 S. 1303-1310


Carmo, H; Brulport, M; Hermes, M et al.

CYP2D6 increases toxicity of the designer drug 4-methylthioamphetamine (4-MTA)

Toxicology. Bd. 229. 2007 S. 236-244